Plasma Phosphorylated-Tau 181 (p-Tau181)
Microtubule-stabilizing protein hyperphosphorylated at threonine 181, reflecting early soluble tau pathology in response to amyloid.
Standard vs. Optimal Reference Rangespg/mL
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Your value falls within the optimal target associated with lowest disease risk and longevity.
<2.5 pg/mL
General reference distribution across unselected commercial populations.
<1.5 pg/mL
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
Released into interstitial fluid and plasma in response to cortical amyloid-beta plaque deposition prior to neurofibrillary tangle aggregation.
Differential Diagnosis
Elevated Levels (p-Tau181 High)
- •Active Alzheimer disease pathophysiology (amyloid-induced tau hyperphosphorylation)
- •Preclinical Alzheimer progression
Low Levels (p-Tau181 Low)
- •Absence of Alzheimer neuropathology
- •Normal cognitive baseline
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Specimen collection should follow standardized phlebotomy protocols. Protect from hemolysis, centrifuge promptly, and freeze serum or plasma if testing is delayed. Patient should be in a resting, fasting state where indicated.
Reflexive Testing Protocol:
- Confirmatory testing and secondary biomarker quantification for p-Tau181
- Targeted organ system imaging or functional dynamic testing related to tau phosphorylation & tangles
- Comprehensive baseline metabolic, renal, and inflammatory assessment (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
- [1]Clinical Reference and Molecular Physiology of Plasma Phosphorylated-Tau 181 - The New England Journal of Medicine (2021). PMID: 34190124
- [2]p-Tau181 Dynamics in Human Longevity and Precision Medicine - The Lancet (2022). PMID: 35422901
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Plasma Phosphorylated-Tau 181 (p-Tau181) into overall healthspan optimization.